Browse by Title

Type here to filter the list

F
Factor Xi Inhibition: Preserving Normal Hemostasis and Preventing Pathologic Thrombosis post MI and Other Thrombotic Syndromes

C. Michael Gibson, MD – Beth Israel Deaconess Medical Center ### 163112###Speaker###Professor of Medicine###Beth Israel Deaconess Medical Center###
Speaker: C. Michael Gibson, MD – Beth Israel Deaconess Medical Center
###
FAME 3 Trial Lessons Learned

William F. Fearon, MD – Stanford University School of Medicine ### 163097###Speaker###Professor of Medicine Director, Interventional Cardiology###Stanford University School of Medicine###
Speaker: William F. Fearon, MD – Stanford University School of Medicine
###
FAST III

Joost Daemen, MD, PhD – Erasmus MC Thoraxcenter ### 309178###Speaker###Interventional Cardiologist###Erasmus MC Thoraxcenter###
Speaker: Joost Daemen, MD, PhD – Erasmus MC Thoraxcenter
### @@@ Jan Tijssen, PhD (he/him/his) – Amsterdam University Medical Centers - University of Amsterdam ### 1902291###Speaker###Emeritus Professor of Clinical Biostatistics###Amsterdam University Medical Centers - University of Amsterdam###
Speaker: Jan Tijssen, PhD (he/him/his) – Amsterdam University Medical Centers - University of Amsterdam
### he/him/his
FDA Commissioner Recorded Fireside Chat
FDA Guidance on Diversity and Clinical Trials

Ariel Ash-Shakoor, PhD – FDA ### 1880295###Speaker###Biomedical Engineer###FDA###
Speaker: Ariel Ash-Shakoor, PhD – FDA
###
FDA Japan: Monday Session (Non-CME)

Kenneth J. Cavanaugh, Jr., PhD – U.S. Food and Drug Administration ### 163054###Program Director###Deputy Director, Office of Cardiovascular Devices###U.S. Food and Drug Administration###
Program Director: Kenneth J. Cavanaugh, Jr., PhD – U.S. Food and Drug Administration
### @@@ Neal E. Fearnot, PhD – Cook Group Incorporated ### 163096###Program Director###Vice President###Cook Group Incorporated###
Program Director: Neal E. Fearnot, PhD – Cook Group Incorporated
###
FDA Japan: Sunday Session (Non-CME)

Kenneth J. Cavanaugh, Jr., PhD – U.S. Food and Drug Administration ### 163054###Program Director###Deputy Director, Office of Cardiovascular Devices###U.S. Food and Drug Administration###
Program Director: Kenneth J. Cavanaugh, Jr., PhD – U.S. Food and Drug Administration
### @@@ Neal E. Fearnot, PhD – Cook Group Incorporated ### 163096###Program Director###Vice President###Cook Group Incorporated###
Program Director: Neal E. Fearnot, PhD – Cook Group Incorporated
###
FDA LUNCEHON

Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai ### 163300###Panel Moderator###Physician###Mount Sinai###
Panel Moderator: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai
### @@@ Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute ### 161917###Panel Moderator###Director, Cardiovascular Research and Advanced Education###MedStar Washington Hospital Center, MedStar Heart and Vascular Institute###
Panel Moderator: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
### @@@ Aneesh Deoras ### 1550672###Panel Discussant#########
Panel Discussant: Aneesh Deoras
### @@@ Andrew Farb, MD – U.S. Food and Drug Administration ### 163094###Panel Discussant###Chief Medical Officer, Division of Cardiovascular Devices###U.S. Food and Drug Administration###
Panel Discussant: Andrew Farb, MD – U.S. Food and Drug Administration
### @@@ Matthew G. Hillebrenner, MSE – U.S. Food and Drug Administration ### 163138###Panel Discussant###Associate Director, Office of Product Evaluation and Quality###U.S. Food and Drug Administration###
Panel Discussant: Matthew G. Hillebrenner, MSE – U.S. Food and Drug Administration
### @@@ Nicole Ibrahim, PhD – U.S. Food and Drug Administration ### 163143###Panel Discussant###Deputy Office Director, OCVD###U.S. Food and Drug Administration###
Panel Discussant: Nicole Ibrahim, PhD – U.S. Food and Drug Administration
### @@@ Rachel Neubrander, PhD – U.S. Food and Drug Administration ### 184742###Panel Discussant###Assistant Division Director###U.S. Food and Drug Administration###
Panel Discussant: Rachel Neubrander, PhD – U.S. Food and Drug Administration
### @@@ Brian Pullin, MS – FDA ### 958540###Panel Discussant###Director, Division of Coronary and Peripheral Intervention Devices###FDA###
Panel Discussant: Brian Pullin, MS – FDA
### @@@ Jaime Raben, PhD – FDA ### 184745###Panel Discussant###Engineer###FDA###
Panel Discussant: Jaime Raben, PhD – FDA
### @@@ Stuart F. Seides, MD, FSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute ### 163288###Panel Discussant###Physician Executive Director###MedStar Washington Hospital Center, MedStar Heart and Vascular Institute###
Panel Discussant: Stuart F. Seides, MD, FSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
### @@@ Changfu Wu, PhD – Food and Drug Administration ### 184772###Panel Discussant###Mechanical Engineer###Food and Drug Administration###
Panel Discussant: Changfu Wu, PhD – Food and Drug Administration
### @@@ Bram Zuckerman, MD – U.S. Food and Drug Administration ### 163359###Panel Discussant###Director Office of CV Devices###U.S. Food and Drug Administration###
Panel Discussant: Bram Zuckerman, MD – U.S. Food and Drug Administration
###
FDA Perspective

Meir Shinnar, MD, PhD – FDA ### 675991###Speaker###Medical Officer###FDA###
Speaker: Meir Shinnar, MD, PhD – FDA
###
FDA Perspectives on Digital Health Apps in Cardiovascular Trials

Kimberly Crowley, MS (she/her/hers) – FDA ### 1878111###Speaker###Biomedical Engineer###FDA###
Speaker: Kimberly Crowley, MS (she/her/hers) – FDA
### she/her/hers
FDA Perspectives on Periprocedural MI in Trials Intended for Regulatory Review

Lydia Glaw, PhD – US FDA ### 1546620###Speaker###Assistant Director###US FDA###
Speaker: Lydia Glaw, PhD – US FDA
###
FDA Valve and Structural Town Hall (Non-CME)

Andrew Farb, MD – U.S. Food and Drug Administration ### 163094###Program Director###Chief Medical Officer, Division of Cardiovascular Devices###U.S. Food and Drug Administration###
Program Director: Andrew Farb, MD – U.S. Food and Drug Administration
### @@@ Aaron V. Kaplan, MD, FSCAI, FACC, FNAI – Dartmouth Health Geisel School of Medicine at Dartmouth ### 185995###Program Director###Professor of Medicine###Dartmouth Health Geisel School of Medicine at Dartmouth###
Program Director: Aaron V. Kaplan, MD, FSCAI, FACC, FNAI – Dartmouth Health Geisel School of Medicine at Dartmouth
### @@@ Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute ### 163174###Program Director###Professor Medicine/Cardiology###Duke University Medical Center/Duke Clinical Research Institute###
Program Director: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
### he/him/his @@@ Changfu Wu, PhD – Food and Drug Administration ### 184772###Program Director###Mechanical Engineer###Food and Drug Administration###
Program Director: Changfu Wu, PhD – Food and Drug Administration
### @@@ Bram Zuckerman, MD – U.S. Food and Drug Administration ### 163359###Program Director###Director Office of CV Devices###U.S. Food and Drug Administration###
Program Director: Bram Zuckerman, MD – U.S. Food and Drug Administration
###
Feasibility And Accuracy Of Holographic Graft Length Measurement, A Sub-study Of The Fast Track Cabg Trial

TsungYing Tsai, MD (he/him/his) – university of Galway ### 1871469###Speaker###PhD student###university of Galway###
Speaker: TsungYing Tsai, MD (he/him/his) – university of Galway
### he/him/his
Feasibility and Safety of Percutaneous Intramyocardial Injection of Alginate-hydrogel Into the Targeted Endocardial Region in A Porcine Model: A Novel Catheter-Based System X-Drop

Patrick W. Serruys, MD, PhD – University of Galway, Ireland ### 163289###Speaker###Professor of Medical Intervention & Innovation###University of Galway, Ireland###
Speaker: Patrick W. Serruys, MD, PhD – University of Galway, Ireland
###
FEATURED CLINICAL SCIENCE SESSION | MONDAY (NON-CME)

Harold L. Dauerman, MD, FSCAI – University of Vermont College of Medicine ### 163076###Moderator###Professor of Medicine and Surgery###University of Vermont College of Medicine###
Moderator: Harold L. Dauerman, MD, FSCAI – University of Vermont College of Medicine
### @@@ Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine ### 163179###Moderator###Professor of Medicine ###Yale School of Medicine###
Moderator: Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine
### @@@ William F. Fearon, MD – Stanford University School of Medicine ### 163097###Panel Discussant###Professor of Medicine Director, Interventional Cardiology###Stanford University School of Medicine###
Panel Discussant: William F. Fearon, MD – Stanford University School of Medicine
### @@@ Allen Jeremias, MD, FSCAI (he/him/his) – St. Francis Hospital, Roslyn, NY ### 184737###Panel Discussant###Associate Director, Cardiac Cath Lab###St. Francis Hospital, Roslyn, NY###
Panel Discussant: Allen Jeremias, MD, FSCAI (he/him/his) – St. Francis Hospital, Roslyn, NY
### he/him/his @@@ Raymond Townsend, MD (he/him/his) – University of Pennsylvania ### 188314###Panel Discussant###Professor###University of Pennsylvania###
Panel Discussant: Raymond Townsend, MD (he/him/his) – University of Pennsylvania
### he/him/his
Featured Clinical Science Session | Monday (Non-CME)
Featured Clinical Science Session | Saturday (Non-CME)
FEATURED CLINICAL SCIENCE SESSION | SATURDAY (NON-CME)

Subhash Banerjee, MD – VA North Texas Health Care System ### 193482###Moderator###Professor of Medicine, UT Southwestern Med. Ctr.Chief of Cardiology, VA North Texas Health Care System###VA North Texas Health Care System###
Moderator: Subhash Banerjee, MD – VA North Texas Health Care System
### @@@ Sanjit S. Jolly, MD, MSc – Population Health Research Institute, Mc Master University, Hamilton Health Sciences ### 163149###Moderator### Professor###Population Health Research Institute, Mc Master University, Hamilton Health Sciences###
Moderator: Sanjit S. Jolly, MD, MSc – Population Health Research Institute, Mc Master University, Hamilton Health Sciences
### @@@ Ian C. Gilchrist, Sr., MD, MSCAI (he/him/his) – Penn State University/Hershey Medical Center ### 163113###Panel Discussant###Professor Of Medicine###Penn State University/Hershey Medical Center###
Panel Discussant: Ian C. Gilchrist, Sr., MD, MSCAI (he/him/his) – Penn State University/Hershey Medical Center
### he/him/his @@@ Michael S. Lee, MD, FACC, FSCAI – UCLA School of Medicine ### 163185###Panel Discussant###Interventional Cardiologist###UCLA School of Medicine###
Panel Discussant: Michael S. Lee, MD, FACC, FSCAI – UCLA School of Medicine
### @@@ Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI – Icahn School of Medicine at Mount Sinai ### 163212###Panel Discussant###Professor of Medicine (Cardiology), and Population Health Science and Policy; Director of Interventional Cardiovascular Research and Clinical Trials###Icahn School of Medicine at Mount Sinai###
Panel Discussant: Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI – Icahn School of Medicine at Mount Sinai
### @@@ Sa'ar Minha, MD (he/him/his) – Shamir Medical Center ### 186938###Panel Discussant###Director, Interventional Cardiology###Shamir Medical Center###
Panel Discussant: Sa'ar Minha, MD (he/him/his) – Shamir Medical Center
### he/him/his @@@ Michael Ragosta, MD – University of Virginia ### 163251###Panel Discussant###Director, Cardiac Catheterization Laboratory###University of Virginia###
Panel Discussant: Michael Ragosta, MD – University of Virginia
###
Featured Clinical Science Session | Sunday (Non-CME)
FEATURED CLINICAL SCIENCE SESSION | SUNDAY (NON-CME)

Davide Capodanno, MD, PhD – Division of Cardiology, CAST, "Policlinico-Vittorio Emanuele", University of Catania ### 309175###Moderator###Associate Professor###Division of Cardiology, CAST, "Policlinico-Vittorio Emanuele", University of Catania###
Moderator: Davide Capodanno, MD, PhD – Division of Cardiology, CAST, "Policlinico-Vittorio Emanuele", University of Catania
### @@@ Maurice Buchbinder, MD, FSCAI – Foundation for Cardiovascular Medicine ### 163045###Panel Discussant###Medical Director###Foundation for Cardiovascular Medicine###
Panel Discussant: Maurice Buchbinder, MD, FSCAI – Foundation for Cardiovascular Medicine
### @@@ Felix Mahfoud, MD – Saarland University Hospital ### 188311###Panel Discussant###Professor###Saarland University Hospital###
Panel Discussant: Felix Mahfoud, MD – Saarland University Hospital
### @@@ Jonathan G. Schwartz, MD (he/him/his) – Sanger Heart & Vascular Institute/Atrium Health ### 1546638###Panel Discussant###Medical Director, Interventional Cardiology###Sanger Heart & Vascular Institute/Atrium Health###
Panel Discussant: Jonathan G. Schwartz, MD (he/him/his) – Sanger Heart & Vascular Institute/Atrium Health
### he/him/his @@@ Andrew SP Sharp, MD – University Hospital of Wales ### 952803###Panel Discussant###Consultant Cardiologist###University Hospital of Wales###
Panel Discussant: Andrew SP Sharp, MD – University Hospital of Wales
### @@@ Molly Szerlip, MD – Baylor Scott and White The Heart Hospital Baylor Plano ### 203491###Panel Discussant###Associate Medical Director, Education & Reserach and Regional Director, Sturctural Heart Progam###Baylor Scott and White The Heart Hospital Baylor Plano###
Panel Discussant: Molly Szerlip, MD – Baylor Scott and White The Heart Hospital Baylor Plano
###
Fem-Pop Stenting: What Guides My Device Selection

D. Christopher Metzger, MD, FSCAI, FACC – Ballad CVA Heart and Vascular Institute ### 163214###Speaker###Interventional Cardiologist ###Ballad CVA Heart and Vascular Institute ###
Speaker: D. Christopher Metzger, MD, FSCAI, FACC – Ballad CVA Heart and Vascular Institute
###
FFR-Angiography: From Concept Into Clinical Practice

Ran Kornowski, MD – Rabin Medical Center ### 163173###Speaker###Chairman, Department of Cardiology###Rabin Medical Center###
Speaker: Ran Kornowski, MD – Rabin Medical Center
###
FINAL REFERRAL AND QUESTION & ANSWER DISCUSSION

Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center ### 185869###Chair###Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease###Georgetown University and MedStar Washington Hospital Center###
Chair: Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center
### @@@ Steven R. Bailey, MD, MSCAI – LSU Health Shreveport ### 163014###Co-Chair###Professor and Chairman, Department of Medicine LSU Health Shreveport###LSU Health Shreveport###
Co-Chair: Steven R. Bailey, MD, MSCAI – LSU Health Shreveport
### @@@ Israel Barbash, MD (he/him/his) – Leviev Heart Center, Sheba Medical Center ### 184729###Judge###Interventional Cardiologist###Leviev Heart Center, Sheba Medical Center###
Judge: Israel Barbash, MD (he/him/his) – Leviev Heart Center, Sheba Medical Center
### he/him/his @@@ Yuval Binur, PhD – Arsuf Global Partners ### 163032###Judge###Managing Partner###Arsuf Global Partners###
Judge: Yuval Binur, PhD – Arsuf Global Partners
### @@@ Tim A. Fischell, MD, FACC – Ascension Borgess Heart Institute ### 163101###Judge###Director of Cardiovascular Research###Ascension Borgess Heart Institute###
Judge: Tim A. Fischell, MD, FACC – Ascension Borgess Heart Institute
### @@@ Nicolas Foin, MSc, PhD – Dhenin/ Duke-NUS ### 203841###Judge###Founder/ Adj Associate Professor###Dhenin/ Duke-NUS###
Judge: Nicolas Foin, MSc, PhD – Dhenin/ Duke-NUS
### @@@ Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona ### 163137###Judge###Interventional Cardiologist###Heart and Vascular Center of Arizona###
Judge: Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona
### @@@ Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center ### 235167###Judge###Director Heart Institute###Hadassah-Hebrew University Medical Center###
Judge: Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center
### @@@ Martin T. Rothman, MD, MBChB – Sofinnova Partners ### 163269###Judge###Medical Technology Consultant###Sofinnova Partners###
Judge: Martin T. Rothman, MD, MBChB – Sofinnova Partners
### @@@ Jonathan G. Schwartz, MD (he/him/his) – Sanger Heart & Vascular Institute/Atrium Health ### 1546638###Judge###Medical Director, Interventional Cardiology###Sanger Heart & Vascular Institute/Atrium Health###
Judge: Jonathan G. Schwartz, MD (he/him/his) – Sanger Heart & Vascular Institute/Atrium Health
### he/him/his @@@ Mark A. Turco, MD – Cardiac Implants ### 163321###Judge###CEO###Cardiac Implants###
Judge: Mark A. Turco, MD – Cardiac Implants
###
Final Thoughts & Adjourn

Maurice Buchbinder, MD, FSCAI – Foundation for Cardiovascular Medicine ### 163045###Speaker###Medical Director###Foundation for Cardiovascular Medicine###
Speaker: Maurice Buchbinder, MD, FSCAI – Foundation for Cardiovascular Medicine
###
Final Thoughts & Adjourn
Final Thoughts and Adjourn
Final Words

Woo-Young Chung, MD – Boramae Medical Center ### 1835469###Speaker###Associate professor###Boramae Medical Center###
Speaker: Woo-Young Chung, MD – Boramae Medical Center
### @@@ Daehyun Hwang, MD – Seoul paik hospital,Inje university ### 880583###Speaker###Professor ###Seoul paik hospital,Inje university###
Speaker: Daehyun Hwang, MD – Seoul paik hospital,Inje university
###
First in Human Experience With a Novel Transfemoral Tricuspid Valve Replacement System (Topaz Valve)

Hendrik Treede, MD – University Heart and Vascular Center Mainz ### 551987###Speaker###Director###University Heart and Vascular Center Mainz###
Speaker: Hendrik Treede, MD – University Heart and Vascular Center Mainz
###
First-In-Human Experience with Third Generation OCT | HF-OCT

Hiram G. Bezerra, MD, PhD – Tampa General / USF ### 163029###Speaker###Interventional Cardiologist###Tampa General / USF###
Speaker: Hiram G. Bezerra, MD, PhD – Tampa General / USF
###
Fishing Stents Day

Sergio Barrera, MD – Hospital Universitario Marqués de Valdecilla ### 1872504###Speaker###Interventional Cardiologist###Hospital Universitario Marqués de Valdecilla###
Speaker: Sergio Barrera, MD – Hospital Universitario Marqués de Valdecilla
###
Fishing Stents’ Day With…

Jose M. De La Torre Hernandez, MD, PhD (he/him/his) – Hospital U. Marques de Valdecilla / IDIVAL ### 316910###Speaker###Interventional Cardiologist, Research Unit###Hospital U. Marques de Valdecilla / IDIVAL###
Speaker: Jose M. De La Torre Hernandez, MD, PhD (he/him/his) – Hospital U. Marques de Valdecilla / IDIVAL
### he/him/his
Five-Year Incidence of Bioprosthetic Valve Dysfunction in Patients Randomized to Surgery or TAVR: Insights from the CoreValve US Pivotal and SURTAVI Trials

Steven J. Yakubov, MD, FACC, MSCAI – OhioHealth/Riverside Methodist Hospital ### 163353###Speaker###System/Medical Chief - Structural Heart Disease###OhioHealth/Riverside Methodist Hospital###
Speaker: Steven J. Yakubov, MD, FACC, MSCAI – OhioHealth/Riverside Methodist Hospital
###
Five-Year Results from the IMPERIAL Randomized Study of Eluvia and Zilver PTX Drug-Eluting Stents and the Long Lesion Substudy for Femoropopliteal Artery Disease

William A. Gray, MD, FSCAI – Main Line Health ### 163121###Speaker###System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute ###Main Line Health###
Speaker: William A. Gray, MD, FSCAI – Main Line Health
###
FLOWer, Total Body Antiembolic Filter

Amar Krishnaswamy, MD – Cleveland Clinic ### 195302###Speaker###Program Director, Interventional Cardiology Fellowship###Cleveland Clinic###
Speaker: Amar Krishnaswamy, MD – Cleveland Clinic
###
FORTHCOMING PATHWAYS IN INTERVENTIONAL CARDIOLOGY | ISCTR @ CRT

Nabil Dib, MD, MSc, FACC – Mercy Gilbert Medical Center/Dignity Health ### 939332###Moderator###Director Cardiovascular Research###Mercy Gilbert Medical Center/Dignity Health###
Moderator: Nabil Dib, MD, MSc, FACC – Mercy Gilbert Medical Center/Dignity Health
### @@@ Spencer B. King, III, MD, MACC, MSCAI – Emory University ### 163166###Moderator###Professor of Medicine Emeritus###Emory University###
Moderator: Spencer B. King, III, MD, MACC, MSCAI – Emory University
### @@@ Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute ### 161917###Moderator###Director, Cardiovascular Research and Advanced Education###MedStar Washington Hospital Center, MedStar Heart and Vascular Institute###
Moderator: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
###
Forthcoming Pharmacological Agents and Trials that Could Impact your Practice late this Decade

C. Michael Gibson, MD – Beth Israel Deaconess Medical Center ### 163112###Speaker###Professor of Medicine###Beth Israel Deaconess Medical Center###
Speaker: C. Michael Gibson, MD – Beth Israel Deaconess Medical Center
###
Fractional Flow Reserve In Left Main Bifurcation From A Single Fluoroscopic View Versus Computed Tomography

Nozomi Kotoku, MD – University of Galway ### 1871486###Speaker###Research fellow ###University of Galway###
Speaker: Nozomi Kotoku, MD – University of Galway
###
Framework for RWE use in Japan

Moe Ohashi, M.S. – Phaumaceutical and Medical Device Agency ### 928959###Speaker###Reviewer###Phaumaceutical and Medical Device Agency###
Speaker: Moe Ohashi, M.S. – Phaumaceutical and Medical Device Agency
###
Free Wall Rupture: A Contemporaneously Rare Complication of Myocardial Infarction

Jason Li, MD – Medstar Georgetown University Hospital ### 1871972###Speaker###Resident Physician###Medstar Georgetown University Hospital###
Speaker: Jason Li, MD – Medstar Georgetown University Hospital
###
From EFS to Pivotal Trials: Lessons Learned

Aaron V. Kaplan, MD, FSCAI, FACC, FNAI – Dartmouth Health Geisel School of Medicine at Dartmouth ### 185995###Speaker###Professor of Medicine###Dartmouth Health Geisel School of Medicine at Dartmouth###
Speaker: Aaron V. Kaplan, MD, FSCAI, FACC, FNAI – Dartmouth Health Geisel School of Medicine at Dartmouth
###
From Tricuspid to Mitral Regurgitation Percutaneous Treatment

Elisha James Ouzan, MD (he/him/his) – Hadassah Hebrew University Medical Center ### 1872211###Speaker###Previous director Of Cardiology department of hospitalization###Hadassah Hebrew University Medical Center###
Speaker: Elisha James Ouzan, MD (he/him/his) – Hadassah Hebrew University Medical Center
### he/him/his
FTR Quantitation: How and What Does It Mean

Maurice Sarano, MD (he/him/his) – Minneapolis Heart Institute ### 1570747###Speaker###Senior Scientist###Minneapolis Heart Institute###
Speaker: Maurice Sarano, MD (he/him/his) – Minneapolis Heart Institute
### he/him/his
Fully Endoscopic Beating Heart Tricuspid Valve Repair in Patients Unsuitable for TEER CardioValve – TR

Hendrik Treede, MD – University Heart and Vascular Center Mainz ### 551987###Speaker###Director###University Heart and Vascular Center Mainz###
Speaker: Hendrik Treede, MD – University Heart and Vascular Center Mainz
###
FUNDAMENTALS OF INTRAVASCULAR IMAGING

Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center ### 163109###Moderator###Director of Invasive Imaging Core Laboratory###MedStar Washington Hospital Center###
Moderator: Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center
### @@@ Akiko Maehara, MD – Columbia University Medical Center ### 163201###Moderator###Professor###Columbia University Medical Center###
Moderator: Akiko Maehara, MD – Columbia University Medical Center
### @@@ Gary S. Mintz, MD – Cardiovascular Research Foundation ### 163215###Moderator###Senior Medical Advisor###Cardiovascular Research Foundation###
Moderator: Gary S. Mintz, MD – Cardiovascular Research Foundation
###
Future Technology Developments: The Role of the ISCTR

Nabil Dib, MD, MSc, FACC – Mercy Gilbert Medical Center/Dignity Health ### 939332###Speaker###Director Cardiovascular Research###Mercy Gilbert Medical Center/Dignity Health###
Speaker: Nabil Dib, MD, MSc, FACC – Mercy Gilbert Medical Center/Dignity Health
###
Futuristic Approach to an Investigational Clinical Trials

Katherine Kumar, PhD, RAC – 4C Medical Technologies, Inc. ### 492584###Speaker###Sr. EVP###4C Medical Technologies, Inc.###
Speaker: Katherine Kumar, PhD, RAC – 4C Medical Technologies, Inc.
###